drugset / Trial / NCT01619176

Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood

NCT01619176

Non-randomizedSingle-groupOpen-labelBasic science

Summary

Acupuncture is used and recommended by the WHO for the treatment of Rheumatoid Arthritis. The molecular bases of this recommendation are not known, the investigators want to compare with the usage of high-throughput molecular technologies the variations occurring in patients treated with acupuncture and conventional treatment with the ones treated with conventional treatment only. The investigators observe the variations in blood and in the gut microbiome.

Timeline

Start
2012-10
Primary completion
2014-12
Completion
2014-12

Publications

  • Results Liu, Y. et al. (2023). Wound Healing from Bench to Bedside: A PPPM Bridge Between Physical Therapies and Chronic Inflammation. In: Podbielska, H., Kapalla, M. (eds) Predictive, Preventive, and Personalised Medicine: From Bench to Bedside. Advances in Predictive, Preventive and Personalised Medicine, vol 17. Springer, Cham. https://doi.org/10.1007/978-3-031-34884-6_12

Drugs

EvaluationDrugModalityDoseRoute
Background Leflunomide Small molecule 20 mg
Background Methotrexate Small molecule 7.5 mg
Background Methotrexate Small molecule 15 mg

Indications